Replies to post #12044 on Revive Therapeutics Ltd (RVVTF)

[Bruinfan4ever]

You clearly don't know what you are talking about. Please stop it.

[Bruinfan4ever]

Just to correct your nonsense Theraflu brings in roughly 280 million a year and that is with a flu vaccine and all the other flu therapeutics out there.

Bucillamine will be used for Covid, the flu, and possibly other diseases as well.

[Beatcovid]

Mr Yoga. Why Not Tell cydy And Countless other Therapeutic Drugs Their Covid Drug is not "viable" with vaccines coming on. Why Did Revive Get your Undivided Attention. I see you Are A Astute Investor/Trader. Yet You have been Circling Revive....

[Cytosphere]

You've poured cold water on RVVTF with incorrect/misleading statements. The news about CMPS can increase interest in RVVTF and the entire sector. There are multiple indications for Bucillamine, and the COVID vaccines have not yet received FDA approval.

[RioDad]

I disagree with two points. If Bucillamine is effective, it makes Vaccines mute. As a pill can quickly cure is better than playing “whack a mole” with A vaccine for SARS-COV-2 strains (it’s already shown 8 mutations).

Then there is the whole “trust a vaccine” aspect as well.

Secondly, RVVTF has more than just “shroom” aspect, they have a delivery method in “breath strips” for the medication. Everyone wants to discount that technology, but if it were so easy, why isn’t it an option for all medicationss?

I know you want to add doubt, but you have no real facts to do that.

[Full Contact Yoga]

Not at all. Simply stated facts comparing the 2 very different companies. Bucilamine may be a good thing. May not. But, they need to find a use beyond COVID 19 because the window on that is pretty short, 5 years max, likely less. But, right now they only have hope, which doesn’t pay the bills. Should have a better idea after the New Year. Until then, nothing to do really but watch the company print paper with every ineffective news blurb and read the posts of the same 3, or fewer, posters. Sad but true.